These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24132166)

  • 1. Promise of human induced pluripotent stem cells in skin regeneration and investigation.
    Ohyama M; Okano H
    J Invest Dermatol; 2014 Mar; 134(3):605-609. PubMed ID: 24132166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cells in dermatology: potentials, advances, and limitations.
    Bilousova G; Roop DR
    Cold Spring Harb Perspect Med; 2014 Nov; 4(11):a015164. PubMed ID: 25368014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
    Galach M; Utikal J
    Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cell technology: a decade of progress.
    Shi Y; Inoue H; Wu JC; Yamanaka S
    Nat Rev Drug Discov; 2017 Feb; 16(2):115-130. PubMed ID: 27980341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
    Yoshida Y; Yamanaka S
    Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells: how they will change the practice of cardiovascular medicine.
    Wong WT; Sayed N; Cooke JP
    Methodist Debakey Cardiovasc J; 2013; 9(4):206-9. PubMed ID: 24298311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the induced pluripotent stem cell-based skin regeneration.
    Choudhury S; Surendran N; Das A
    Wound Repair Regen; 2021 Sep; 29(5):697-710. PubMed ID: 33970525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regenerative medicine in cosmetic dermatology.
    Boddu S; Hashim PW; Nia JK; Horowitz R; Farberg A; Goldenberg G
    Cutis; 2018 Jan; 101(1):33-36. PubMed ID: 29529112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of induced pluripotent stem cell technology for the investigation of hematological disorders.
    Dolatshad H; Tatwavedi D; Ahmed D; Tegethoff JF; Boultwood J; Pellagatti A
    Adv Biol Regul; 2019 Jan; 71():19-33. PubMed ID: 30341008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iPS cell technologies and cartilage regeneration.
    Tsumaki N; Okada M; Yamashita A
    Bone; 2015 Jan; 70():48-54. PubMed ID: 25026496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.
    Meneghini V; Frati G; Sala D; De Cicco S; Luciani M; Cavazzin C; Paulis M; Mentzen W; Morena F; Giannelli S; Sanvito F; Villa A; Bulfone A; Broccoli V; Martino S; Gritti A
    Stem Cells Transl Med; 2017 Feb; 6(2):352-368. PubMed ID: 28191778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cells in dermatology.
    Ogliari KS; Marinowic D; Brum DE; Loth F
    An Bras Dermatol; 2014; 89(2):286-91. PubMed ID: 24770506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future prospects for regenerated heart using induced pluripotent stem cells.
    Fujita J; Fukuda K
    J Pharmacol Sci; 2014; 125(1):1-5. PubMed ID: 24739283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Road to future: iPSC clinical application in Parkinson's disease treatment.
    Xu L; Tan YY; Wu L; Wang LL; Li H; Ding JQ; Chen SD
    Curr Mol Med; 2013 Nov; 13(9):1412-8. PubMed ID: 23971738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cell therapy for Parkinson's disease with induced pluripotent stem cells].
    Morizane A
    Rinsho Shinkeigaku; 2019 Mar; 59(3):119-124. PubMed ID: 30814448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury.
    Kramer AS; Harvey AR; Plant GW; Hodgetts SI
    Cell Transplant; 2013; 22(4):571-617. PubMed ID: 22944020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted reversion of induced pluripotent stem cells from patients with human cleidocranial dysplasia improves bone regeneration in a rat calvarial bone defect model.
    Saito A; Ooki A; Nakamura T; Onodera S; Hayashi K; Hasegawa D; Okudaira T; Watanabe K; Kato H; Onda T; Watanabe A; Kosaki K; Nishimura K; Ohtaka M; Nakanishi M; Sakamoto T; Yamaguchi A; Sueishi K; Azuma T
    Stem Cell Res Ther; 2018 Jan; 9(1):12. PubMed ID: 29357927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.